EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC 4.0

Adverse effects of dorsogluteal intramuscular injection versus ventrogluteal intramuscular injection: A systematic review and meta‐analysis

María Teresa Roldán-Chicano iD, Javier Rodríguez-Tello iD, Raquel Cebrián-López iD, James Richard Moore iD, María Del Mar García-López iD

Nursing Open · 2023

DOI: 10.1002/nop2.1902 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Nursing Open, 2023. Verfasst von María Teresa Roldán-Chicano und 4 weiteren Autor:innen. Beteiligte Einrichtung: Santa Lucia, University General Hospital, Murcia Health Service, Cartagena, Spain. Hauptthemen laut MEDLINE: Muscle, Skeletal, Subcutaneous Fat. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To determine adverse effects of ventrogluteal intramuscular injections versus dorsogluteal intramuscular injections.

Design

A systematic review and meta‐analysis.

Methods

MEDLINE, EMBASE, CINHAL, CENTRAL, LILACS(BVS), BDENF (BVS), WoS, IRCTP(WHO), ClinicalsTrials.gov and PROSPERO databases were searched with no restriction on year or language. Preferred Reporting items for Systematic Reviews and Meta‐Analyses (PRISMA) guidelines were followed.

Results

A total of 1429 participants from 17 studies were included. The meta‐analysis found that ventrogluteal injection site had significant relation to lower pain in 9 studies (SMD = −0.63, 95% CI = −0.87, −0.39), bleeding in 4 studies (SMD = −3.46, 95% CI = −6.07, –0.86) and hematoma in 2 studies; after 48 h (SMD = −0.25, 95% CI = −0.39, −0.11), and after 72 h (SMD = −0.16, 95% CI = −0.26, –0.06), if it was compared with dorsogluteal site injection. No differences were found when comparing the possibility of intramuscular injections given into de subcutaneous tissue. In three studies, ventrogluteal site did not significantly reduce the risk of subcutaneous injection (OR 0,62, 95% CI = 0.16, 2.41).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscle, SkeletalSubcutaneous FatHumansInjections, IntramuscularButtocksSubcutaneous Tissue

Stichwörter der Autor:innen

adverse effectsbuttocksdorsoglutealinjectionsintramuscularintramuscular/adverse effects*intramuscular/methods*nursingsubcutaneoussystematic reviewventrogluteal

Autor:innen und Institutionen

  • Santa Lucia, University General Hospital, Murcia Health Service, Cartagena, Spain.
  • Cartagena School of Nursing, Murcia University, Cartagena, Spain.
  • Murcia Health Service, Cartagena, Spain.
  • Isaac Peral Health Center, Cartagena, Murcia Health Service, Cartagena, Spain.

ORCID-Profile: María Teresa Roldán-Chicano, Javier Rodríguez-Tello, Raquel Cebrián-López, James Richard Moore, María Del Mar García-López

Zitieren

APA

Roldán-Chicano, M. T., Rodríguez-Tello, J., Cebrián-López, R., Moore, J. R., & Del Mar García-López, M. (2023). Adverse effects of dorsogluteal intramuscular injection versus ventrogluteal intramuscular injection: A systematic review and meta‐analysis. Nursing Open. https://doi.org/10.1002/nop2.1902

Vancouver

Roldán-Chicano MT, Rodríguez-Tello J, Cebrián-López R, Moore JR, Del Mar García-López M. Adverse effects of dorsogluteal intramuscular injection versus ventrogluteal intramuscular injection: A systematic review and meta‐analysis. Nursing Open. 2023. doi:10.1002/nop2.1902

BibTeX
@article{RoldnChicano2023,
  author = {Roldán-Chicano, María Teresa and Rodríguez-Tello, Javier and Cebrián-López, Raquel and Moore, James Richard and Del Mar García-López, María},
  title = {Adverse effects of dorsogluteal intramuscular injection versus ventrogluteal intramuscular injection: A systematic review and meta‐analysis},
  journal = {Nursing Open},
  year = {2023},
  doi = {10.1002/nop2.1902}
}
Kostenlos starten →